Proceedings of the National Academy of Sciences · 1989 · 137 citations · 31 references
Life SciencesChemical BiologyMolecular BiologyMolecular VirologyRna ProcessingVirologyAntiviral PharmacologyAntiviral TherapyRna InterferenceViral InfectionsViral Rna BiologyViral TranscriptionAlternative Splicing In VirusesAntiviral TherapeuticsBinding Site SpecificityImmediate Early Gene ExpressionImmediate Early GenesNucleoside ModificationPsoralen PharmacologyRecognition Site Specificity
Oligo(nucleoside methylphosphonate)s complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5 caused specific inhibition of herpes simplex virus type 1 growth. The dodecamer d(TpTCCTCCTGCGG) (deoxynucleoside methylphosphonate residues in italic) caused 50% and 98% decreases in herpes simplex virus type 1 titers at concentrations of 15 microM and 100 microM, respectively. d(TpTCCTCCTGCGG) inhibited viral but not cellular protein synthesis and decreased splicing of immediate early pre-mRNAs 4 and 5. Inhibition was highly sequence specific. A psoralen derivative of d(TpTCCTCCTGCGG) that can covalently bind to complementary sequences after exposure to 365-nm irradiation caused 90-98% inhibition of virus growth in cells treated with oligomer (5 microM) and irradiated at 1-3 hr postinfection. The data suggest that oligo(nucleoside methylphosphonate)s of appropriate sequence and derivatization may be effective as antiviral agents.
31
Makoto Matsukura, Kazuo Shinozuka, Gerald Zon et al. · Proceedings of the National Academy of Sciences · 1987 · 535 citations · Full text